Claudine Bruck serves as Executive at NAVIDEA BIOPHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Claudine Bruck has executed 14 insider transactions totaling $14.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 10, 2025 involved exercising options for 7,142 shares valued at $1000.
Claudine Bruck currently holds 13,709 shares of NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Claudine Bruck has been a net buyer of NAVB stock. They have purchased $14.7K and sold $0 worth of shares.
Claudine Bruck's most recent insider trade was on Sep 10, 2025, when they sold 7,142 shares at $0.14 per share.
Get notified when new Form 4 filings are submitted
| $6.07 |
| Discretionary |
| Nov 20, 2023 | ANVS | $0 | Other | 0 | $N/A | Discretionary |
| Apr 7, 2023 | ANVS | $6.3K | Award | 500 | $12.61 | Discretionary |
| Oct 11, 2021 | ANVS | $5.0K | Purchase | 181 | $27.66 | Discretionary |
| Jun 30, 2021 | NAVB | $0 | Award | 3,969 | $N/A | Discretionary |
| Jan 13, 2021 | NAVB | $0 | Award | 2,500 | $N/A | Discretionary |
| Feb 6, 2020 | NAVB | $0 | Award | 2,500 | $N/A | Discretionary |
| Jan 31, 2020 | ANVS | $0 | Conversion | 3,969 | $N/A | Discretionary |
| Jan 31, 2020 | ANVS | $5.4K | Conversion | 1,117 | $4.80 | Discretionary |
| Jan 31, 2020 | ANVS | $4.8K | Purchase | 800 | $6.00 | Discretionary |
| May 13, 2019 | NAVB | $4.8K | Purchase | 2,550 | $1.90 | Discretionary |
| Feb 7, 2019 | NAVB | $0 | Award | 50,000 | $N/A | Discretionary |
| Mar 15, 2018 | NAVB | $0 | Award | 50,000 | $N/A | Discretionary |